Succinic Acid

Succinic Acid

SCHEMBL126337

O=C([O-])CCC(=O)[O-].[H+].[H+]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRB1CDK4CDK6CHRM2CHRM3DPP4DRD2DRD3DRD4EGFRHRH1HTR1BHTR1DHTR1FHTR2AHTR2CHTR4SLC6A2SLC6A4

The experimentally established mechanism targets of Succinic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Succinic Acid SCHEMBL105372 0.96
Succinic Acid SCHEMBL4325320 0.96
Succinic Acid SCHEMBL104933 0.96
Succinic Acid SCHEMBL11211761 0.96 HDAC3 (0.59)
Succinic Acid SCHEMBL107798 0.96
Succinic Acid SCHEMBL9181910 0.91 FFAR3 (0.56)
Succinic Acid SCHEMBL22471655 0.91 FFAR3 (0.56)
Succinic Acid SCHEMBL1665207 0.91 FFAR3 (0.56)
Succinic Acid SCHEMBL21958270 0.91 FFAR3 (0.56)
Succinic Acid SCHEMBL21958272 0.91 FFAR3 (0.56)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1044 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12503713-B1 Stabilization of tryptamines by denaturing enzymes, optimizing ionization states, and controlling confounding variables Convergent Health Sciences LLC (US) 2025-12-23 US claimed
US-12497637-B1 Stabilization of tryptamines by denaturing enzymes, optimizing ionization states, and controlling confounding variables Convergent Health Sciences LLC (US) 2025-12-16 US claimed
CN-119546295-A Medical active substance 炎症药物有限责任公司 2025-02-28 CN claimed
CN-111448177-B Aqueous composition comprising 2- (dimethyl-1H-pyrazol-1-yl) succinic acid and ammonia 巴斯夫欧洲公司 2025-01-10 CN claimed
CN-118414729-A Modified current collector for secondary battery 广东省皓智科技有限公司 2024-07-30 CN claimed
EP-3411029-B1 SUCCINATE SALT OF CYTISINE AND USE THEREOF ACHIEVE PHARMA UK LTD (GB) 2023-11-01 EP claimed
EP-4265298-A2 SALT Achieve Pharma UK Limited (GB) 2023-10-25 EP claimed
US-11725006-B2 Hydrophilic berberine-type derivative and application thereof in preparing drug INSTITUTE OF MATERIA MEDIC, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) 2023-08-15 US claimed
CN-111295369-B Carbonic acid adducts 炎症药物有限责任公司 2023-07-25 CN claimed
US-11696581-B2 Monoterpenoid/phenylpropanoid-containing compounds and methods of their making and use as seed treatments KITTRICH CORPORATION (US) 2023-07-11 US claimed
US-5059511-A Curable silicone rubber layer on light sensitive resin of (meth)acryloyl and allyl monomers, photoinitiators FUJI PHOTO FILM CO., LTD. (JP) 1991-10-22 US claimed
US-5034379-A Antiulcer agents for treatment of lesions from antiinflammatory agents RAINSFORD KIM D (CA) 1991-07-23 US claimed
EP-0154523-B1 A PHARMACEUTICAL FORMULATION CONTAINING AZAPROPAZONE Rainsford, Kim Drummond (GB) 1989-03-22 EP claimed
EP-0232813-A2 N6-substituted Adenosines WARNER-LAMBERT COMPANY (US) 1987-08-19 EP claimed
EP-0154523-A2 A pharmaceutical formulation containing azapropazone Rainsford, Kim Drummond (GB) 1985-09-11 EP claimed
US-4479959-A 8-CHLORO-1-/ HYDROXYMETHYL/ -6-PHENYL-4H-S-TRIAZOLO/4,3-ALL1,4/ BENZODIAZEPINE THE UPJOHN COMPANY (US) 1984-10-30 US claimed
US-4302471-A USING A DIESTER OF EPININE SIMES SOCIETA ITALIAN MEDICINALI E SINTETICI S.P.A. (IT) 1981-11-24 US claimed
US-4277498-A Amides BURROUGHS WELLCOME CO. (US) 1981-07-07 US claimed
US-4268694-A HYDROLYSIS OF TETRAHALOCYCLOHEXANONE FISONS LIMITED (GB) 1981-05-19 US claimed
US-4165374-A ANTIARRHYTHMIA, ANTILEPEMIC, HYPOGLYCEMIC SANDOZ LTD. (CH) 1979-08-21 US claimed